Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation A modelling analysis from the Euro Heart Survey

Ron Pisters; Robby Nieuwlaat; Deirdre A. Lane; Harry J. G. M. Crijns; Gregory Y. H. Lip

doi:10.1160/TH12-08-0539

Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation A modelling analysis from the Euro Heart Survey

Ron Pisters, Robby Nieuwlaat, Deirdre A. Lane, Harry J. G. M. Crijns, Gregory Y. H. Lip^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

44 Citations (Web of Science)

Original language	English
Pages (from-to)	328-336
Journal	Thrombosis and Haemostasis
Volume	109
Issue number	2
DOIs	https://doi.org/10.1160/TH12-08-0539
Publication status	Published - Feb 2013

Keywords

Atrial fibrillation
oral anticoagulation
stroke prevention

Access to Document

10.1160/TH12-08-0539

Cite this

@article{f36b64ce58e04ade926b81a039f685dd,

title = "Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation A modelling analysis from the Euro Heart Survey",

keywords = "Atrial fibrillation, oral anticoagulation, stroke prevention",

author = "Ron Pisters and Robby Nieuwlaat and Lane, {Deirdre A.} and Crijns, {Harry J. G. M.} and Lip, {Gregory Y. H.}",

year = "2013",

month = feb,

doi = "10.1160/TH12-08-0539",

language = "English",

volume = "109",

pages = "328--336",

journal = "Thrombosis and Haemostasis",

issn = "0340-6245",

publisher = "Georg Thieme Verlag",

number = "2",

}

Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation A modelling analysis from the Euro Heart Survey. / Pisters, Ron; Nieuwlaat, Robby; Lane, Deirdre A.; Crijns, Harry J. G. M.; Lip, Gregory Y. H.

In: Thrombosis and Haemostasis, Vol. 109, No. 2, 02.2013, p. 328-336.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation A modelling analysis from the Euro Heart Survey

AU - Pisters, Ron

AU - Nieuwlaat, Robby

AU - Lane, Deirdre A.

AU - Crijns, Harry J. G. M.

AU - Lip, Gregory Y. H.

PY - 2013/2

Y1 - 2013/2

KW - Atrial fibrillation

KW - oral anticoagulation

KW - stroke prevention

U2 - 10.1160/TH12-08-0539

DO - 10.1160/TH12-08-0539

M3 - Article

VL - 109

SP - 328

EP - 336

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

SN - 0340-6245

IS - 2

ER -